Caxton Associates (New York)’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-7,730
Closed -$585K – 617
2021
Q3
$585K Hold
7,730
– – 0.06% 180
2021
Q2
$773K Buy
+7,730
New +$717K 0.08% 104
2020
Q3
– Sell
-82,100
Closed -$5.44M – 414
2020
Q2
$5.44M Buy
+82,100
New +$5.23M 0.47% 34
2020
Q1
– Sell
-19,880
Closed -$1.67M – 491
2019
Q4
$1.67M Buy
+19,880
New +$1.56M 0.23% 56

Other funds holding ITRI

Caxton Associates (New York)'s ITRI Position: Q4 2021 in Review

Caxton Associates (New York) sold out of Itron (ITRI) in Q4 2021, closing a stake of 7,730 shares — an estimated $585K sold.

Caxton Associates (New York) first reported a position in ITRI in Q4 2019 and held it in 4 quarters. The position peaked at $5.44M in Q2 2020. 261 funds tracked by Wall St. Rank hold ITRI as of Q4 2021.

  • Caxton Associates (New York) reported no remaining Itron position as of Q4 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 7,730 Itron shares in Q4 2021, an estimated $585K.
  • Caxton Associates (New York) first reported a position in Itron in Q4 2019 and held it in 4 quarters.
  • Caxton Associates (New York)'s Itron position peaked at $5.44M in Q2 2020.
  • 261 funds tracked by Wall St. Rank held Itron as of Q4 2021.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.